Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease
You'll see more attention paid to the management of nonalcoholic fatty liver disease (NAFLD)...as it becomes more common.
Up to 100 million Americans have this buildup of fat in the liver...usually without any symptoms. It often goes hand in hand with obesity, dyslipidemia, insulin resistance, and diabetes.
About 20% of patients with NAFLD have nonalcoholic steatohepatitis (NASH)...the more severe form with inflammation and sometimes fibrosis.